DexCom
- Market cap
- 31.81B
- P/E (TTM)i
- 33.32
- P/Bi
- 12.13
- EPSi
- 2.09
- Div yieldi
- 0.00%
- 52W posi
- 78%
Anonymous reader poll. Unscientific, not investment advice.
✦ Quant Ownership Signal how this is computed
- The number of reporting institutions decreased by 11 in the most recent period (2026/Q3).
- Total institutional ownership fell 0.4 percentage points.
Institutional ownership
- Held by institutions
- 105.19% -0.40pp
- Institutions
- 1,210 -11
- As of
- 2026/Q3 vs. prior period
Ownership vs. money flow
AlignedInstitutions trimmed shares last reporting period, and the stock has seen net outflows in main-fund flow over the last 20 trading sessions - the two line up.
Institutional ownership changes are reported quarterly with a lag; fund-flow data is daily. Treat this as a directional cross-check, not a precise timing signal.
Holder types
Top holders as of 2026-06-30
Bar length is relative to the largest holder shown here, not to 100% of the company.
Insiders
50 filings tracked · 14 buys · 35 sells
| Name | Role | Stake |
|---|---|---|
| Jacob Leach | Chief Operating Officer | 0.09% |
| Kevin Sayer | Chairperson & CEO | 0.05% |
| Steven Altman | Independent Director | 0.02% |
| Jereme Sylvain | Chief Financial Officer | 0.02% |
| Sadie Stern | Executive Vice President | 0.01% |
| Mark Foletta | Lead Independent Director | 0.01% |
| Richard Collins | Independent Director | 0.01% |
| Nicholas Augustinos | Independent Director | 0.01% |
| Michael Brown | Chief Legal Officer | 0.01% |
| Bridgette Heller | Independent Director | 0.01% |
Insider transactions most recent Form 4 filings
| Date | Name | Role | Type | Shares | Price |
|---|---|---|---|---|---|
| 2026-09-27 | Sadie Stern | Executive Vice President | Automatic Disposition | -2,565 | $86.15 |
| 2026-09-14 | Nicholas Augustinos | Independent Director | Automatic Disposition | -8,089 | $84.02–84.04 |
| 2026-09-14 | Nicholas Augustinos | Independent Director | Intent to Sell (Form 144) | -6,539 | $84.04 |
| 2026-09-14 | Michael Brown | Chief Legal Officer | Automatic Disposition | -1,700 | $84.04 |
| 2026-09-13 | Nicholas Augustinos | Independent Director | Intent to Sell (Form 144) | -1,550 | $84.02 |
| 2026-09-09 | Glenn Boehnlein | Independent Director | Other Acquisition | +5,841 | -- |
| 2026-09-09 | Glenn Boehnlein | Independent Director | Initial Statement of Beneficial | 0 | -- |
| 2026-09-09 | Jereme Sylvain | Chief Financial Officer | Automatic Disposition | -3,638 | $83.27 |
| 2026-08-26 | Sadie Stern | Executive Vice President | Automatic Disposition | -2,565 | $88.37 |
| 2026-08-21 | Jacob Leach | Chief Operating Officer | Sale to Issuer | -1,451 | $92.34 |
| 2026-08-21 | Jereme Sylvain | Chief Financial Officer | Sale to Issuer | -1,451 | $92.34 |
| 2026-08-21 | Sadie Stern | Executive Vice President | Sale to Issuer | -1,451 | $92.34 |
| 2026-08-21 | Michael Brown | Chief Legal Officer | Sale to Issuer | -1,451 | $92.34 |
| 2026-08-19 | Kevin Sayer | Chairperson & CEO | Automatic Disposition | -26,756 | $89.71–91.41 |
| 2026-08-13 | Michael Brown | Chief Legal Officer | Automatic Disposition | -1,700 | $91.93 |
| 2026-08-11 | Nicholas Augustinos | Independent Director | Other Disposition | -1,075 | -- |
| 2026-08-11 | Bridgette Heller | Independent Director | Automatic Disposition | -1,012 | $88.29 |
| 2026-08-02 | Mark Foletta | Lead Independent Director | Intent to Sell (Form 144) | -2,000 | $85.32 |
| 2026-08-02 | Mark Foletta | Lead Independent Director | Automatic Disposition | -4,000 | $80.00–85.32 |
| 2026-07-30 | Mark Foletta | Lead Independent Director | Intent to Sell (Form 144) | -2,000 | $80.00 |
Form 4 filings, most recent per company. "Other Derivative Acquisition" rows are mostly RSU/option vesting, not open-market buying - the Type column says which.
Quote time 2026-10-08 08:22:36 · For reference only, not investment advice and not tailored to your situation.